Correlation between gene polymorphisms of Wnt signalling pathway related components and risk of gastric carcinoma: a case-control study.
- Author:
Hong-ping ZHENG
1
;
Wen ZHOU
;
Li-hong XU
;
Jian-min SI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Base Sequence; Case-Control Studies; Female; Gene Frequency; Genotype; Glycogen Synthase Kinase 3; genetics; metabolism; Glycogen Synthase Kinase 3 beta; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Sequence Analysis, DNA; Sex Factors; Signal Transduction; Stomach Neoplasms; enzymology; genetics; Wnt Proteins; genetics; metabolism; beta Catenin; genetics; metabolism
- From: Chinese Journal of Medical Genetics 2006;23(6):647-651
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate correlation between polymorphisms of rs3755557 and rs1880481 located in glycogen synthase kinase 3beta gene and beta-catenin gene respectively, the products of which are components of Wnt signalling pathway, and risk of gastric carcinoma.
METHODSPCR and denaturing high-performance liquid chromatography combining with DNA sequencing were used to analyse genotype polymorphism of rs3755557 and rs1880481 of the subjects including 26 patients of gastric carcinoma and 33 patients of chronic superficial gastritis.
RESULTSChi-square analysis revealed that there was no significant difference in the frequencies of alleles and genotypes of rs3755557 polymorphic site between gastric carcinoma group and control group. As to the rs1880481 polymorphic site, there was no significant difference in the frequencies of alleles between gastric carcinoma group and the corresponding control group. The frequency of heterozygous genotype in male control group was 68.18% and it was significantly higher than 26.67% in male gastric carcinoma group, OR=5.893, 95%CI: 1.377-25.226 (P=0.013); but the frequencies of AA genotype of the site in male control group and male gastric carcinoma group were 9.09% and 40.00% respectively. There was statistical significance, OR=6.667, 95% CI: 1.121-39.660 (P=0.025).
CONCLUSIONThe above results suggest that the genotypes and alleles of rs3755557 site do not contribute to the risk of gastric carcinoma. Low level of the heterozygous genotype or high level of AA genotype of rs1880481 polymorphic site in male patients might cause a higher risk of developing gastric carcinoma.
